IP Pharmacist Suspended After 70,000+ Unsafe Prescriptions

Date of Decision: March 27, 2026

Registrant's Role: Pharmacist

Allegations:

• Prescribed or approved approximately 70,618 prescriptions, including thousands of high-risk medicines, without adequate clinical safeguards
• Routinely failed to follow prescribing guidance by: Not obtaining sufficient patient medical information; Relying primarily on online questionnaires; Failing to access GP or specialist records; Not conducting appropriate consultations (face-to-face or virtual); Failing to assess risks of dependency or misuse; Not referring patients to their GP when needed; Failing to implement appropriate safety-netting
• Prescribed high-risk medications (e.g. opioids, z-drugs, modafinil, propranolol, amitriptyline, and weight-loss drugs such as orlistat and Saxenda) based solely on questionnaires
• Prescribed codeine to a patient with known or identifiable risk factors for dependence without proper checks
• Continued prescribing repeat medications without considering prior supply history, misuse risk, or need for monitoring
• Oversaw a high volume of unsafe prescribing as Clinical Lead within a deficient online prescribing model
• Adopted a “transactional” approach to prescribing driven by questionnaire responses rather than clinical judgment
• Continued working for an unregistered pharmacy without adequate regard for regulatory status

Outcome: Suspension for 12 months

GPhC Standards Breached:

• Standard 1 – Provide person-centred care
• Standard 2 – Work in partnership with others
• Standard 3 – Communicate effectively
• Standard 4 – Maintain, develop and use professional knowledge and skills
• Standard 5 – Use professional judgement
• Standard 8 – Speak up when concerns arise
• Standard 9 – Demonstrate leadership

Case Summary

Original Case Document